Answers are grounded in this paper and cite their sources.
Narrative review reveals therapeutic phytoconstituents from twenty-two medicinal plants for diabetes, highlighting cost-effective and safer alternatives for pharmaceutical drug development.
Diabetes is a metabolic syndrome increasing rapidly due to occupational stress, lack of physical activity, sedentary lifestyle and increasing occurrence of obesity, associated with rapidly growing urbanization and industrialization. Due to erroneous carbohydrate metabolism, diabetics are more prone to chronic complications like nephropathy, neuropathy, retinopathy, coronary artery disease and peripheral arterial disease resulting in tissue damage. Current treatment protocols to these problems produce more serious adverse effects and are costly too. Medicinal plants provide an alternative of safe, reliable and cost-effective pharmacological source to all these ailments. This review provides the compiled data of isolated active phytoconstituents of 22 potent antidiabetic plants with their plant-part used, which might be useful for drug development.
No takes yet. Share an insight, caveat, or question.
Rajnish Gupta (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: